Extend your brand profile by curating daily news.

American Fusion Reduces Authorized Shares, Secures $793,000 in Financing for Technology Development

By Advos
American Fusion Inc. has cut its authorized shares from 3 billion to 1.8 billion and secured $793,000 in financing to support corporate operations and fusion energy commercialization.

Found this article helpful?

Share it with your network and spread the knowledge!

American Fusion Reduces Authorized Shares, Secures $793,000 in Financing for Technology Development

American Fusion Inc. (OTC: AMFN) announced it has reduced its authorized common shares from 3.0 billion to 1.8 billion following the cancellation of approximately 1.683 billion shares, resulting in about 1.316 billion shares outstanding. The move is part of efforts to align the company's capital structure with current needs, according to a press release.

The company also reported receiving approximately $793,000 in year-to-date financing under a fixed-price prepaid warrant structure as part of a broader $3 million commitment. Proceeds from the financing will support corporate operations, technology development, and commercialization initiatives.

American Fusion is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The company is advancing the Texatron aneutronic fusion platform, designed for modular, infrastructure-grade deployment across industrial, commercial, and grid-constrained applications.

The company's development strategy emphasizes system-level engineering, disciplined intellectual property protection, and scalable architectures intended to support long-term commercial operation, while maintaining a focus on capital discipline and transparent corporate governance.

This capital structure adjustment and financing update are significant for investors as they indicate the company's commitment to strengthening its financial foundation and advancing its fusion technology. The reduction in authorized shares may help prevent dilution, while the secured financing provides necessary capital for research and development.

For more information, visit the company's newsroom at http://ibn.fm/AMFN.

Advos

Advos

@advos